With a bit of controversy over sequencing costs, now it is loud and clear – sequencing is going to become even more affordable thanks to Illumina’s “MiniSeq” announced at the JPMorgan Annual Healthcare conference. With this trend of RNA-seq becoming accessible like never before, soon more biobanks and personalized medicine centers will have the capacity for sequencing.
A good read about the differences is found here: http://bit.ly/1W1pVmA. In my opinion it is definitely a positive trend that will lead to an explosion of NGS data that has to be useful. Here is a good post about analysis tools also becoming more accessible: http://bit.ly/1KapeRb